Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Environment, Development and Sustainability|August 15, 2022
Impacts of digitalization on energy security: evidence from European countriesTo Trung Thanh, Le Thanh Ha, Hoang Phuong Dung, et al.
Heliyon|April 9, 2025
Retraction notice to "Disaster risk management system in Vietnam: progress and challenges" [Heliyon 8 (2022) e10701]Tran Thi Lan Huong, Duong Thi Van Anh, Tran Tho Dat, et al.
Heliyon|October 7, 2022
Disaster risk management system in Vietnam: progress and challengesTran Thi Lan Huong, Duong Thi Van Anh, Tran Tho Dat, et al.
Bioorganic Chemistry|February 16, 2017
Novel N-hydroxybenzamides incorporating 2-oxoindoline with unexpected potent histone deacetylase inhibitory effects and antitumor cytotoxicityTran-Thi-Lan Huong, Do-Thi-Mai Dung, Nguyen-Van Huan, et al.
Natural Product Communications|May 6, 2009
A new rearranged abietane diterpene and other constituents from Clerodendrum philipinumHa Van Oanh, Pham Xuan Sinh, Nguyen Thai An, et al.
Molecules (Basel, Switzerland)|April 28, 2023
Development of Activity Rules and Chemical Fragment Design for In Silico Discovery of AChE and BACE1 Dual Inhibitors against Alzheimer's DiseaseLe-Quang Bao, Daniel Baecker, Do Thi Mai Dung, et al.
Bioorganic & Medicinal Chemistry|March 7, 2025
Design, synthesis and biological evaluation of novel hydroxamic acid-derived histone deacetylase inhibitors bearing a 2-oxoindoline scaffold as potential antitumor agentsTran Thi Lan Huong, Hwa Kyung Kim, Nguyen Duc Thien, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|September 27, 2014
5-aryl-1,3,4-thiadiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents: synthesis, bioevaluation and docking studyTran Thi Lan Huong, Do Thi Mai Dung, Dao Thi Kim Oanh, et al.
RSC Advances|July 14, 2026
2-Oxoindoline-based hydroxamic acids: novel HDAC inhibitors with promising anticancer activityTran Thi Lan Huong, Hwa Kyung Kim, Nguyen Anh Thai, et al.
Pageof 1